BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18245812)

  • 1. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis.
    Englert JM; Hanford LE; Kaminski N; Tobolewski JM; Tan RJ; Fattman CL; Ramsgaard L; Richards TJ; Loutaev I; Nawroth PP; Kasper M; Bierhaus A; Oury TD
    Am J Pathol; 2008 Mar; 172(3):583-91. PubMed ID: 18245812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical function for the receptor for advanced glycation end products in mouse models of pulmonary fibrosis.
    Englert JM; Kliment CR; Ramsgaard L; Milutinovic PS; Crum L; Tobolewski JM; Oury TD
    Int J Clin Exp Pathol; 2011 Mar; 4(3):241-54. PubMed ID: 21487520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the receptor for advanced glycation end-products in a murine model of silicosis.
    Ramsgaard L; Englert JM; Tobolewski J; Tomai L; Fattman CL; Leme AS; Kaynar AM; Shapiro SD; Enghild JJ; Oury TD
    PLoS One; 2010 Mar; 5(3):e9604. PubMed ID: 20333255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP.
    Kyung SY; Byun KH; Yoon JY; Kim YJ; Lee SP; Park JW; Lee BH; Park JS; Jang AS; Park CS; Jeong SH
    Int J Clin Exp Pathol; 2014; 7(1):221-8. PubMed ID: 24427342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
    Ohlmeier S; Mazur W; Salmenkivi K; Myllärniemi M; Bergmann U; Kinnula VL
    Proteomics Clin Appl; 2010 Jan; 4(1):97-105. PubMed ID: 21137019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the receptor for advanced glycation end-products in lung fibrosis.
    He M; Kubo H; Ishizawa K; Hegab AE; Yamamoto Y; Yamamoto H; Yamaya M
    Am J Physiol Lung Cell Mol Physiol; 2007 Dec; 293(6):L1427-36. PubMed ID: 17951314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types.
    Queisser MA; Kouri FM; Königshoff M; Wygrecka M; Schubert U; Eickelberg O; Preissner KT
    Am J Respir Cell Mol Biol; 2008 Sep; 39(3):337-45. PubMed ID: 18421017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis.
    Ding H; Ji X; Chen R; Ma T; Tang Z; Fen Y; Cai H
    Pulm Pharmacol Ther; 2015 Dec; 35():34-41. PubMed ID: 26545872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation.
    Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Fujitaka K; Hamada H; Hattori N
    Respir Investig; 2022 Jul; 60(4):531-542. PubMed ID: 35504814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis.
    Yamaguchi K; Iwamoto H; Horimasu Y; Ohshimo S; Fujitaka K; Hamada H; Mazur W; Kohno N; Hattori N
    Respirology; 2017 Jul; 22(5):965-971. PubMed ID: 28198072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transition.
    Song JS; Kang CM; Park CK; Yoon HK; Lee SY; Ahn JH; Moon HS
    Exp Mol Med; 2011 Sep; 43(9):517-24. PubMed ID: 21743278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced receptor for advanced glycation end products is associated with α-SMA expression in patients with idiopathic pulmonary fibrosis and mice.
    Baek H; Jang S; Park J; Jang J; Lee J; Hong SH; Kim WJ; Park SM; Yang SR
    Lab Anim Res; 2021 Oct; 37(1):28. PubMed ID: 34600594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor for advanced glycation end products (RAGE) and the lung.
    Buckley ST; Ehrhardt C
    J Biomed Biotechnol; 2010; 2010():917108. PubMed ID: 20145712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.
    Manichaikul A; Sun L; Borczuk AC; Onengut-Gumuscu S; Farber EA; Mathai SK; Zhang W; Raghu G; Kaufman JD; Hinckley-Stukovsky KD; Kawut SM; Jelic S; Liu W; Fingerlin TE; Schwartz DA; Sell JL; Rich SS; Barr RG; Lederer DJ
    Ann Am Thorac Soc; 2017 May; 14(5):628-635. PubMed ID: 28248552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary delivery of a recombinant RAGE antagonist peptide derived from high-mobility group box-1 in a bleomycin-induced pulmonary fibrosis animal model.
    Piao C; Zhuang C; Ko MK; Hwang DW; Lee M
    J Drug Target; 2022 Aug; 30(7):792-799. PubMed ID: 35451894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
    Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
    Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells.
    Buckley ST; Medina C; Kasper M; Ehrhardt C
    Am J Physiol Lung Cell Mol Physiol; 2011 Apr; 300(4):L548-59. PubMed ID: 21278261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE).
    Hanford LE; Enghild JJ; Valnickova Z; Petersen SV; Schaefer LM; Schaefer TM; Reinhart TA; Oury TD
    J Biol Chem; 2004 Nov; 279(48):50019-24. PubMed ID: 15381690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice.
    Ramsgaard L; Englert JM; Manni ML; Milutinovic PS; Gefter J; Tobolewski J; Crum L; Coudriet GM; Piganelli J; Zamora R; Vodovotz Y; Enghild JJ; Oury TD
    PLoS One; 2011; 6(5):e20132. PubMed ID: 21629785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model.
    Aleshin A; Ananthakrishnan R; Li Q; Rosario R; Lu Y; Qu W; Song F; Bakr S; Szabolcs M; D'Agati V; Liu R; Homma S; Schmidt AM; Yan SF; Ramasamy R
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1823-32. PubMed ID: 18245563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.